What is LOPJLB’s current signal on HRMY?

LOPJLB’s latest quantitative signal on Harmony Biosciences Holdings, Inc. (HRMY) is SELL in a BEAR regime. Signals are updated daily.

What market regime is HRMY in?

Harmony Biosciences Holdings, Inc. (HRMY) is currently classified in the BEAR HMM market regime on LOPJLB.

Where is Harmony Biosciences Holdings, Inc. based / listed?

Harmony Biosciences Holdings, Inc. is based in US, listed on NASDAQ.

Harmony Biosciences Holdings, Inc. (HRMY)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$40.28+1.72%Close

SELLBEAR · day 10

RANGE

DATA 2026-10-09

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $2.3B
Beta: 1.01
P/E (TTM): 12.58

Short % float: 10.98%
Days to cover: 5.0
SI change: +19.5%

1W: +1.61%
1M: -2.00%

vs SPY 1W: +0.45%
vs SPY 1M: -4.99%

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical firm dedicated to developing and marketing therapies for individuals in the United States who suffer from rare neurological conditions. Their flagship product, WAKIX, is a prescription medication designed…

Employees: 293
Headquarters: US
Founded: 2020
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 57.9M
Float: 87.0%

harmonybiosciences.com ↗

Key executives

Jeffrey Dayno — President, Chief Executive Officer & Director

Adam Zaeske — Executive Vice President & Chief Commercial Officer

Kumar Budur — Executive Vice President and Chief Medical & Scientific Officer

SEC filings

EDGAR · CIK 18026650 · HRMY

Analyst consensus

Buy

Bullish861.5%

Neutral323.1%

Bearish215.4%

L $34.00Avg $49.00H $70.00

Target$49.00+21.65%

Last$40.28

Key stats

Industry peers

Prediction markets

Company news